drugset / Trial / NCT02706119

Insulin in Total Parenteral Nutrition

NCT02706119

Phase 4 Completed 163 enrolled Fundación Pública Andaluza Progreso y Salud
RandomizedParallel-groupOpen-labelScreening

Summary

Analyze the level of metabolic control achieved with a routine of regular insulin in the parenteral nutrition (PN) reservoir in addition to subcutaneous glargine insulin, versus only regular insulin in the PN reservoir.

Timeline

Start
2016-07-01
Primary completion
2018-03-31
Completion
2018-04-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic
Subject insulin glargine Protein / enzyme biologic Subcutaneous

Indications